Del 26 al 27 de octubre, la Universidad de Estudios de Padua acogió la reunión de lanzamiento del recién iniciado #Proyecto IMPACT (Cardiogenomics meets Artificial Intelligence: un paso adelante en el diagnóstico y tratamiento de la cardiomiopatía arritmogénica), financiado por la Unión Europea.
IMPACT brings together seven partners from Italy, France and the Netherlands and has the overall aim of better understanding the role and impact of known genes and epigenetic factors on susceptibility, clinical progression, and treatment of Arrhythmogenic Cardiomyopathy (ACM), a genetic disease that in turn lead to the occurrence of ventricular arrhythmias and sudden cardiac death.
All the partners from the consortium will work together to combine large-scale data from genomics, proteomics and instrumental analysis obtained from patients with data from structural and functional analyses of in vitro and in vivo models.
During this two-days event all the partners had the chance to present their research groups and all the activities that will be carried out during the course of the three-years project.
Stay tuned and follow us for more news on IMPACT upcoming results!
ES 
ES 
FR 
TI 
PL 
DE 
NL 
BG 
CS 
RRHH 
DA 
ET 
FI 
EL 
AG 
LV 
LT 
MT 
PT 
RO 
SK 
SL 
HU 
SV